Vital Therapies Announces Upcoming Third Quarter Financial Results Conference Call With Webcast
October 18, 2017 08:01 ET
|
Vital Therapies, Inc.
SAN DIEGO, Oct. 18, 2017 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver...
Navigators to Announce its Third Quarter 2017 Financial Results on Thursday, November 2, 2017
October 06, 2017 16:10 ET
|
The Navigators Group, Inc.
STAMFORD, Conn., Oct. 06, 2017 (GLOBE NEWSWIRE) -- The Navigators Group, Inc. (NASDAQ:NAVG) will announce its third quarter financial results after the close of regular stock market hours on...
Navigators Estimates Natural Catastrophe Losses for Third Quarter
October 05, 2017 16:01 ET
|
The Navigators Group, Inc.
STAMFORD, Conn., Oct. 05, 2017 (GLOBE NEWSWIRE) -- The Navigators Group, Inc. (NASDAQ:NAVG) today announced that its estimated financial impact from natural catastrophes in the third quarter will...
Lantronix to Report Fiscal 2017 Third Quarter Results on April 27, 2017
April 13, 2017 08:15 ET
|
Lantronix Inc.
IRVINE, Calif., April 13, 2017 (GLOBE NEWSWIRE) -- Lantronix, Inc. (NASDAQ:LTRX), a global provider of secure data access and management solutions for Internet of Things (IoT) and information...
Vital Therapies Announces Third Quarter Financial Results
November 03, 2016 16:01 ET
|
Vital Therapies, Inc.
SAN DIEGO, Nov. 03, 2016 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver...
Fate Therapeutics to Webcast Conference Call Reporting Third Quarter 2016 Financial Results on November 7, 2016
October 31, 2016 16:01 ET
|
Fate Therapeutics, Inc.
SAN DIEGO, Oct. 31, 2016 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ:FATE), a biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and...
ATN Reports Third Quarter and Nine Month 2016 Results
October 26, 2016 17:02 ET
|
ATN International, Inc.
Third Quarter 2016 Financial Highlights: Revenues: $138.8 millionAdjusted EBITDA1: $46.4 millionOperating income: $22.1 millionNet income attributable to ATN’s stockholders: $7.2 million, or $0.44...
Vital Therapies Announces Upcoming Third Quarter Financial Results Conference Call With Webcast
October 25, 2016 16:01 ET
|
Vital Therapies, Inc.
SAN DIEGO, Oct. 25, 2016 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq:VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver...
ATN International Sets Date To Report Third Quarter 2016 Results
October 17, 2016 14:36 ET
|
ATN International, Inc.
BEVERLY, Mass., Oct. 17, 2016 (GLOBE NEWSWIRE) -- ATN (NASDAQ:ATNI) announced today that it will report results for the third quarter ended September 30, 2016 on Wednesday, October 26, 2016, at...
ATN Reports Third Quarter and Nine Month 2015 Results
October 28, 2015 17:05 ET
|
ATN International, Inc.
Third Quarter 2015 Highlights: Revenues of $96.8 millionAdjusted EBITDA1 of $39.7 millionOperating income of $22.5 million included $2.5 million of transaction-related costsNet income...